Your browser doesn't support javascript.
loading
Immunodeficiency in Bloom's Syndrome.
Schoenaker, Michiel H D; Henriet, Stefanie S; Zonderland, Jip; van Deuren, Marcel; Pan-Hammarström, Qiang; Posthumus-van Sluijs, Sandra J; Pico-Knijnenburg, Ingrid; Weemaes, Corry M R; IJspeert, Hanna.
Afiliación
  • Schoenaker MHD; Department of Pediatric Infectious Diseases and Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Henriet SS; Department of Pediatric Infectious Diseases and Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Zonderland J; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
  • van Deuren M; Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Pan-Hammarström Q; Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden.
  • Posthumus-van Sluijs SJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
  • Pico-Knijnenburg I; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
  • Weemaes CMR; Department of Pediatric Infectious Diseases and Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • IJspeert H; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. h.ijspeert@erasmusmc.nl.
J Clin Immunol ; 38(1): 35-44, 2018 01.
Article en En | MEDLINE | ID: mdl-29098565
Bloom's syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair, we aimed to study if BLM deficiency affects T and B cell development and especially somatic hypermutation (SHM) and class switch recombination (CSR) processes. Clinical data of six BS patients was collected, and immunoglobulin serum levels were measured at different time points. In addition, we performed immune phenotyping of the B and T cells and analyzed the SHM and CSR in detail by analyzing IGHA and IGHG transcripts using next-generation sequencing. The serum immunoglobulin levels were relatively low, and patients had an increased number of infections. The absolute number of T, B, and NK cells were low but still in the normal range. Remarkably, all BS patients studied had a high percentage (20-80%) of CD4+ and CD8+ effector memory T cells. The process of SHM seems normal; however, the Ig subclass distribution was not normal, since the BS patients had more IGHG1 and IGHG3 transcripts. In conclusion, BS patients have low number of lymphocytes, but the immunodeficiency seems relatively mild since they have no severe or opportunistic infections. Most changes in the B cell development were seen in the CSR process; however, further studies are necessary to elucidate the exact role of BLM in CSR.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Bloom / Linfocitos B / Linfocitos T / RecQ Helicasas / Síndromes de Inmunodeficiencia / Mutación Límite: Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Immunol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Bloom / Linfocitos B / Linfocitos T / RecQ Helicasas / Síndromes de Inmunodeficiencia / Mutación Límite: Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Immunol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos